IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
|Official Title:||Resonance Magnetic Imaging at the Acute Phase of Endocarditis: Diagnostic and Therapeutic Impact|
- Modification of therapeutic project [ Time Frame: As soon as RMI is performed ] [ Designated as safety issue: No ]
- Modification of diagnostic classification (Duke modified criteria) [ Time Frame: As soon as RMI is performed ] [ Designated as safety issue: No ]
|Study Start Date:||June 2005|
|Study Completion Date:||December 2008|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
|No Intervention: 1||
Behavioral: Modification of therapy
Modification of the surgery date if adapted, modification of the antibiotics if adapted, based on RMI results
Patients with definite or possible infective endocarditis are included in this protocol, at the acute phase of the disease.
Resonance magnetic imaging (head and abdomen) will be performed systematically before Day 7.
The impact on the diagnosis and therapeutic options will be assessed, as compared to pre resonance magnetic nuclear (RMN) imaging declaration.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00144885
|Hôpital Bichat Claude Bernard, 46 rue Henri Huchard|
|Paris, France, 75877|
|Principal Investigator:||Xavier Duval||Hôpital Bichat, Assistance Publique Hôpitaux de Paris|